Skip to main content

Advertisement

SpringerLink
Log in

Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma

  • Clinical study - patient study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Objectives The optimal treatment for elderly patients (age >70 years) with glioblastoma (GBM) remains controversial. We conducted a prospective trial in 43 consecutive elderly patients with GBM treated with hypofractionated radiotherapy (RT) followed by adjuvant temozolomide. Patients and methods Forty-three patients 70 years of age or older with a newly diagnosed GBM and a Karnofsky performance status (KPS) ≥ 60 were treated with hypofractionated RT (6 fractions of 5 Gy each for a total of 30 Gy over 2 weeks) followed by up to 12 cycles of adjuvant temozolomide (150–200 mg/m2 for 5 days during each 28 day cycle). The HRQOL was assessed with the EORTC Quality of Life Questionnaire C30. The primary endpoint was overall survival (OS). Secondary endpoints included progression free survival (PFS), toxicity and quality of life. Results The median OS was 9.3 months and the median PFS was 6.3 months. The 6 and 12 month survival rates were 86% and 35%, respectively. The 6 and 12 month PFS rates were 55% and 12%, respectively. In multivariate analysis KPS was the only significant independent predictive factor of survival (P = 0.008). Neurological deterioration occurred during or after RT in 16% of patients and was resolved in most cases with the use of steroids. Grade 3–4 hematologic toxicity occurred in 28% of patients during the adjuvant chemotherapy treatment with temozolomide. The treatment had no negative effect on HRQOL, however, fatigue (P = 0.02) and constipation (P = 0.01) scales worsened over time. Conclusions Hypofractionated RT followed by temozolomide may provide survival benefit maintaining a good quality of life in elderly patients with GBM. It may represent a reasonable therapeutic approach especially in patients with less favourably prognostic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fleury A, Menegoz F, Grosclaude P et al (1997) Descriptive epidemiology of cerebral gliomas in France. Cancer 79:1195–2202. doi :10.1002/(SICI)1097-0142(19970315)79:6<1195::AID-CNCR19>3.0.CO;2-V

  2. Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer 104:2798–2806. doi:10.1002/cncr.21539

    Article  PubMed  Google Scholar 

  3. Whittle IR, Denholm SW, Gregor A et al (1991) Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 36:106–111. doi:10.1016/0090-3019(91)90227-Z

    Article  PubMed  CAS  Google Scholar 

  4. Curran WJ Jr, Scott CB, Horton J et al (1993) Recursive partition analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704–710. doi:10.1093/jnci/85.9.704

    Article  PubMed  Google Scholar 

  5. Meckling S, Dold O, Forsyth PA et al (1996) Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47:901–905

    PubMed  CAS  Google Scholar 

  6. Bauman GS, Fisher BJ, Halperin EC et al (1994) A prospective study of short course RT in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29:835–839

    PubMed  CAS  Google Scholar 

  7. Thomas R, James N, Guerrero D et al (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33:113–116. doi:10.1016/0167-8140(94)90064-7

    Article  PubMed  CAS  Google Scholar 

  8. Ford JM, Stenning SP, Bootle DJ et al (1997) A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol (R Coll Radiol) 9:20–24. doi:10.1016/S0936-6555(97)80053-2

    CAS  Google Scholar 

  9. Hoegler DB, Davey P (1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33(3):201–214. doi:10.1023/A:1005750111883

    Article  PubMed  CAS  Google Scholar 

  10. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981–987. doi:10.1016/S0360-3016(98)00296-X

    PubMed  CAS  Google Scholar 

  11. Villa S, Bertoni F, Bossi A et al (1998) Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42:977–980. doi:10.1016/S0360-3016(98)00356-3

    PubMed  CAS  Google Scholar 

  12. Glantz M, Chamberlain M, Liu Q et al (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262–2266. doi:10.1002/cncr.11323

    Article  PubMed  CAS  Google Scholar 

  13. McAleese JJ, Stenning SP, Ashley S et al (2003) Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother Oncol 67:177–182. doi:10.1016/S0167-8140(03)00077-X

    Article  PubMed  CAS  Google Scholar 

  14. Roa W, Brasher PMA, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1593–1598. doi:10.1200/JCO.2004.06.082

    Article  Google Scholar 

  15. Keime-Guiber F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535. doi:10.1056/NEJMoa065901

    Article  Google Scholar 

  16. Brandes AA, Vastola F, Basso U (2003) A prospective Study in glioblastoma multiforme. Cancer 3:657–662. doi:10.1002/cncr.11097

    Article  Google Scholar 

  17. Combs SE, Wagner J, Bischof M, Welzel T, Wagner F, Debus J et al (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70:987–992. doi:10.1016/j.ijrobp.2007.07.2368

    PubMed  Google Scholar 

  18. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M et al (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88(1):97–103. doi:10.1007/s11060-008-9538-0

    Article  PubMed  CAS  Google Scholar 

  19. Sijben AE, McIntyre JB, Roldán GB, Easaw JC, Yan E, Forsyth PA et al (2008) Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol. doi:10.1007/s11060-008-9593-6

    PubMed  Google Scholar 

  20. MacDonald DR, Cascino TL, Schold SC Jr et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    PubMed  CAS  Google Scholar 

  21. Chinot OL, Barrie M, Frauger E et al (2004) Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100:2208–2214. doi:10.1002/cncr.20224

    Article  PubMed  CAS  Google Scholar 

  22. Chamberlain MC, Chalmers L (2007) A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol 82:207–209. doi:10.1007/s11060-006-9269-z

    Article  PubMed  Google Scholar 

  23. Mirimanoff RO, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. Clin Oncol 24:2563–2569. doi:10.1200/JCO.2005.04.5963

    Article  CAS  Google Scholar 

  24. Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL et al (2008) The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma. J Neurooncol 88:43–50. doi:10.1007/s11060-008-9530-8

    Article  PubMed  CAS  Google Scholar 

  25. Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003. doi:10.1056/NEJMoa043331

    Article  PubMed  CAS  Google Scholar 

  26. Stuschke M, Eberhardt W, Pöttgen C et al (1999) Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 17:2700–2709

    PubMed  CAS  Google Scholar 

  27. Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395. doi:10.1016/j.ijrobp.2007.03.048

    PubMed  Google Scholar 

  28. Stupp R, Mason W, Van der Bent M et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352:987–996. doi:10.1056/NEJMoa043330

    Article  PubMed  CAS  Google Scholar 

  29. Lanzetta G, Campanella C, Rozzi A et al (2003) Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159–5164

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Neurooncology Research Grants from the University of Rome “La Sapienza”, Rome, and NEUROMED Institute, Pozzilli (IS), Italy.

Author information

Authors and Affiliations

  1. Department of Radiotherapy Oncology, Sant’ Andrea Hospital, University “La Sapienza”, Via di Grottarossa 1035, 00189, Rome, Italy

    Giuseppe Minniti, V. De Sanctis, R. Muni, M. F. Osti, M. Valeriani & R. Maurizi Enrici

  2. Department of Neurological Sciences, Neuromed Institute, Pozzilli, IS, Italy

    Giuseppe Minniti, G. Lanzetta, M. Salvati & G. P. Cantore

  3. Department of Medical Oncology, Sant’ Andrea Hospital, University “La Sapienza”, Rome, Italy

    D. Rasio

  4. Department of Neuroradiology, Sant’ Andrea Hospital, University “La Sapienza”, Rome, Italy

    A. Bozzao

Authors
  1. Giuseppe Minniti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. De Sanctis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Muni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Rasio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Lanzetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Bozzao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. F. Osti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Salvati
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Valeriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. P. Cantore
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R. Maurizi Enrici
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Minniti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minniti, G., De Sanctis, V., Muni, R. et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neurooncol 91, 95–100 (2009). https://doi.org/10.1007/s11060-008-9689-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9689-z

Keywords

Search

Navigation